16th Jun 2014 13:00
LONDON (Alliance News) - Biopharmaceutical company Oxford Biomedica PLC Monday said a group of directors including Chairman Nick Rodgers purchased a total of 136.2 million shares among them as part of the biopharmaceutical company's recent fund raising. Non-Executive Director Martin Diggle purchase by far the largest amount of shares, increasing his holding to 21.38%.
Oxford BioMedica PLC said earlier Monday it had raised GBP21.6 million through a firm fund-raising and under-subscribed open offer, falling short of its targeted GBP25.7 million. Oxford paced 1.0 billion shares at 2 pence in the firm placing, raising GBP20 million. It also launched an open offer of up to 283.2 million shares at the same price.
It received acceptances for 78.4 million shares, equivalent to 27.7%, raising GBP1.57 million.
Details the director share purchases are as follows.
Name of Director | Title | Number of Ordinary Shares Purchased | Number of Ordinary Shares beneficially held immediately following Admission | Percentage of issued ordinary shares beneficially held immediately following Admission |
Nick Rodgers | Non-Executive Chairman | 200,000 | 1,042,829 | 0.04% |
John Dawson | Chief Executive Officer | 500,000 | 2,782,829 | 0.11% |
Peter Nolan | Senior Vice President, Commercial Development | 150,000 | 883,313 | 0.04% |
Tim Watts | Chief Financial Officer | 1,625,000 | 5,307,829 | 0.21% |
Dr. Paul Blake | Non-Executive Director | 1,250,000 | 1,783,097 | 0.07% |
Dr. Andrew Heath | Non-Executive Director | 250,000 | 850,000 | 0.03% |
Martin Diggle | Non-Executive Director | 132,250,000 | 533,250,100 | 21.38% |
Shares were down 2.4% at 2.00 pence Monday afternoon.
By Arvind Bhunjun; [email protected]; @ArvindBhunjun
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Oxford Biomedica